Giacomo Basadonna to Graft Survival
This is a "connection" page, showing publications Giacomo Basadonna has written about Graft Survival.
Connection Strength
0.797
-
Rothstein DM, Livak MF, Kishimoto K, Ariyan C, Qian HY, Fecteau S, Sho M, Deng S, Zheng XX, Sayegh MH, Basadonna GP. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J Immunol. 2001 Jan 01; 166(1):322-9.
Score: 0.163
-
Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Onodera H, Lazarovits AI, Basadonna GP. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation. 1997 May 15; 63(9):1355-8.
Score: 0.126
-
Lee LS, Auersvald LA, Claus EB, Bia MJ, Friedman AL, Lorber MI, Basadonna GP. Body size mismatch between donor and recipient and the development of chronic rejection in renal transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):111.
Score: 0.124
-
Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Basadonna GP. Anti-CD45RB treatment prolongs islet allograft survival in mice. Transplant Proc. 1997 Feb-Mar; 29(1-2):771.
Score: 0.124
-
Basadonna GP, Arrazola L, Matas AJ, Gruessner R, Schmidt W, Sutherland DE. Morbidity, mortality, and long-term allograft function in kidney transplantation alone and simultaneous pancreas-kidney in diabetic patients. Transplant Proc. 1993 Feb; 25(1 Pt 2):1321-2.
Score: 0.094
-
Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Ricordi C, Rothstein DM, Basadonna GP, Inverardi L. Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes. 2003 Apr; 52(4):957-64.
Score: 0.047
-
Molano RD, Berney T, Pileggi A, Ricordi C, Burkly L, Rothstein D, Basadonna G, Inverardi L. Prolonged survival of allogeneic islet grafts in NOD mice treated with a combination of anti-CD45RB and anti-CD154 antibodies. Transplant Proc. 2001 Feb-Mar; 33(1-2):248-9.
Score: 0.041
-
Basadonna G, Matas AJ, Najarian JS. Kidney transplantation in diabetic patients: the University of Minnesota experience. Kidney Int Suppl. 1992 Oct; 38:S193-6.
Score: 0.023
-
Magee JC, Barr ML, Basadonna GP, Johnson MR, Mahadevan S, McBride MA, Schaubel DE, Leichtman AB. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant. 2007; 7(5 Pt 2):1424-33.
Score: 0.015
-
Sho M, Kishimoto K, Harada H, Livak M, Sanchez-Fueyo A, Yamada A, Zheng XX, Strom TB, Basadonna GP, Sayegh MH, Rothstein DM. Requirements for induction and maintenance of peripheral tolerance in stringent allograft models. Proc Natl Acad Sci U S A. 2005 Sep 13; 102(37):13230-5.
Score: 0.014
-
Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, Sharpe A, Sayegh MH, Basadonna GP, Rothstein DM. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J Immunol. 2003 Dec 01; 171(11):5673-7.
Score: 0.012
-
Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol. 2001 Jan; 2(1):58-63.
Score: 0.010
-
Merrell R, Basadonna G, Montorsi F. [Current status of pancreatic island transplantation]. Minerva Chir. 1985 Mar 15; 40(5):239-42.
Score: 0.003